Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Preferences for Treatments for Hepatocellular Cancer (HCC) in Japan

NCT02616692 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02616692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02616692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Preferences for Treatments for Hepatocellular Cancer (HCC) in Japan
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 9, 2016
Completion date
October 7, 2016
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer